Conference item icon

Conference item : Abstract

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/annrheumdis-2018-eular.1275

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
ORCID:
0000-0002-4756-663X
Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Journal:
Annals of the Rheumatic Diseases Journal website
Volume:
77
Issue:
S2
Pages:
379-380
Host title:
Annals of the Rheumatic Diseases
Publication date:
2018-06-12
Acceptance date:
2018-03-15
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
Source identifiers:
930947
Subtype:
Abstract
Pubs id:
pubs:930947
UUID:
uuid:8a089bda-a133-4d45-a70f-262a222add23
Local pid:
pubs:930947
Deposit date:
2019-06-06

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP